Clinical Trial Update: The Effectiveness and Safety of LIVIA® Transcutaneous Electrical Nerve Stimulation (TENS) in Women Suffering From Primary Dysmenorrhea. [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 trial evaluating the effectiveness and safety of LIVIA Transcutaneous Electrical Nerve Stimulation (TENS) for women w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• LIVIA Transcutaneous Electrical Nerve Stimulation (TENS)

Snippet

Sponsor: iPulse Medical Ltd. (Livia) | Conditions: Dysmenorrhea | Phase 2 | Status: COMPLETED